The Recall Desk

FDA (Drugs) recall action 93867

Teva Pharmaceuticals USA, Inc recalled 2 products on 2024-02-21

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2024-02-21
Critical
0
Units
32,740

Why these products were recalled

Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

1–2 of 2

  • ModerateFDA (Drugs)··2024-02-21

    Nortrel 7/7/7 Oral Contraceptive Recalled for Discolored Tablets

    Teva Pharmaceuticals is recalling Nortrel 7/7/7 oral contraceptive tablets due to a manufacturing defect: discolored blue tablets mixed with white inert tablets. This could cause confusion about which tablets to take in the triphasic regimen.

    Product
    NORTREL 7/7/7 (NORETHINDRONE AND ETHINYL ESTRADIOL)
    Category
    Distribution
    0 states